Format
Sort by

Send to

Choose Destination

Search results

Items: 2

1.

Once-daily atazanavir/ritonavir versus twice-daily lopinavir/ritonavir, each in combination with tenofovir and emtricitabine, for management of antiretroviral-naive HIV-1-infected patients: 48 week efficacy and safety results of the CASTLE study.

Molina JM, Andrade-Villanueva J, Echevarria J, Chetchotisakd P, Corral J, David N, Moyle G, Mancini M, Percival L, Yang R, Thiry A, McGrath D; CASTLE Study Team.

Lancet. 2008 Aug 23;372(9639):646-55. doi: 10.1016/S0140-6736(08)61081-8.

PMID:
18722869
2.

[The first 5 years of the AIDS outbreak in Mexico].

Ponce de León S, Macías AE, Cruz A, Calva J, Carlos Tinoco J, Ruiz C, Ojeda F, Bobadilla M, Lilia Rolón A, Villalobos I, et al.

Salud Publica Mex. 1988 Jul-Aug;30(4):544-54. Spanish. No abstract available.

PMID:
3187746

Supplemental Content

Loading ...
Support Center